Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Galena Biopharma Inc    GALE

Delayed Quote. Delayed  - 06/29 09:59:59 pm
0.35 USD   -82.76%
06/29 WEDNESDAY SECTO : Biotechnology, Waste Management Stocks
06/29 Galena Biopharma Discontinues NeuVax™ (nelipepimut-S) Phase..
06/14 GALENA BIOPHARM : Presents GALE-401 Combined Safety Data at the Euro..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/23/2016 06/24/2016 06/27/2016 06/28/2016 06/29/2016 Date
2.15(c) 2.1(c) 2.01(c) 2.03(c) 0.35(c) Last
5 195 253 3 288 830 3 113 851 1 956 621 79 979 094 Volume
-5.29% -2.33% -4.29% +1.00% -82.76% Change
More quotes
Financials ($)
Sales 2016 -
EBIT 2016 -38,4 M
Net income 2016 -52,3 M
Debt 2016 -
Yield 2016 -
Sales 2017 2,50 M
EBIT 2017 -41,0 M
Net income 2017 -44,6 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales2016 0
Capi. / Sales2017 25,5x
Capitalization 63,6 M
More Financials
Company
Galena Biopharma, Inc. engages as a biopharmaceutical company committed to the development and commercialization of targeted oncology therapeutics that address major unmet medical needs.It focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of... 
Sector
Pharmaceuticals
Calendar
07/14Shareholder meeting
More about the company
Surperformance© ratings of Galena Biopharma Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on GALENA BIOPHARMA INC
06/29 WEDNESDAY SECTOR LAGGARDS : Biotechnology, Waste Management Stocks
06/29 GALENA BIOPHARMA, INC. : Financial Statements and Exhibits (form 8-K)
06/29 Galena Biopharma Discontinues NeuVax™ (nelipepimut-S) Phase 3, PRESENT ..
06/28 GALENA BIOPHARMA, INC. : Other Events (form 8-K)
06/14 GALENA BIOPHARMA : Presents GALE-401 Combined Safety Data at the European Hemato..
06/13 Galena Biopharma Presents GALE-401 Combined Safety Data at the European Hemat..
06/11 GALENA BIOPHARMA : Receives Two Orphan Drug Designations for GALE-301 and GALE-3..
06/10 Galena Biopharma Receives Two Orphan Drug Designations for GALE-301 and GALE-..
06/06 Galena Biopharma Presents GALE-301 Phase 1/2a Primary Analysis at the America..
06/02 GALENA BIOPHARMA : Receives Fast Track Designation for NeuVax (nelipepimut-S) PR..
More news
Sector news : Pharmaceuticals - NEC
12:10p JOHNSON & JOHNSON : SIMPONI® Receives European Commission Approval for Treatment..
11:10a EISAI : listed for 15th Consecutive Year FTSE4Good Index Series, an Index for So..
09:13a ASTRAZENECA : *jefferies raises astrazeneca price target to 4450 pence - 'hold'
08:51aDJMONSANTO : Shops Around For 'Right Combination' -- WSJ
08:10a DAIICHI SANKYO : FTSE Russell Corporation Selects Daiichi Sankyo for FTSE4Good G..
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
06/29 Midday Gainers / Losers
06/29 HEALTHCARE - TOP 5 GAINERS / LOSERS : 10
06/29 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
06/29 Galena's stops late-stage study of NeuVax in breast cancer due to lack of eff..
06/23 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
Advertisement
Chart GALENA BIOPHARMA INC
Duration : Period :
Galena Biopharma Inc Technical Analysis Chart | GALE | US3632561086 | 4-Traders
Full-screen chart
Technical analysis trends GALENA BIOPHARMA INC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions